SLVO:NASDAQETRACS Silver Shares Covered Call ETNs due April 21, 2033 Analysis
Data as of 2026-08-02 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
SLVO is trading at $62.63, well under its 20‑day ($63.80), 50‑day ($71.84) and 200‑day ($89.03) simple moving averages, signaling a sustained bearish bias. The 14‑day RSI of 40.4 suggests modest oversold pressure, yet the MACD histogram (+0.56) hints at a tentative bullish crossover, leaving short‑term direction uncertain. With a support level near $61.20 and resistance at $68.25, price action is confined to a tight range amid a 30‑day volatility of roughly 49% and a beta of 1.16, indicating amplified moves relative to the broader market. The fund’s expense ratio of 0.65% and a modest dividend yield of 0.69% provide some income, but a historic max drawdown of –42% underscores the downside risk inherent in a single‑commodity, covered‑call structure. The Fear & Greed Index at 92.9 (Extreme Greed) reflects a market environment that may be over‑optimistic on risk assets, which could further pressure SLVO’s price if silver’s momentum stalls. Overall, the technical profile, high volatility, and concentrated exposure suggest caution, with income benefits offset by limited upside potential.
Market Outlook
Short Term
< 1 yearKey Factors
- price below all major SMAs indicating bearish trend
- high 30‑day volatility and beta above 1
- proximity to support with limited upside to resistance
Medium Term
1–3 yearsKey Factors
- covered‑call premium provides modest dividend yield
- tracking error is zero, ensuring tight index replication
- potential for a short‑term rally if silver rebounds
Long Term
> 3 yearsKey Factors
- covered‑call overlay caps upside in a commodity‑driven vehicle
- historical max drawdown of over 40% highlights downside risk
- high sector concentration limits diversification benefits
Key Metrics & Analysis
Fund Metrics
Technical Analysis
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.